Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing

Journal of Controlled Release

Volumn 59, Issue 1, 1999, Pages 107-118

  Másson, Már ^a   Loftsson, Thorsteinn ^a   Másson, Gísli ^b   Stefánsson, Einar ^c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cyclodextrins; Hydrocortisone; Permeability; Skin; Transdermal flux

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETAZOLAMIDE; CYCLODEXTRIN; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROPYLMETHYLCELLULOSE; PENETRATION ENHANCING AGENT; POVIDONE; TRIAMCINOLONE ACETONIDE;

ARTICLE; DIFFUSION; DRUG SOLUBILITY; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; SKIN PERMEABILITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL MEMBRANE PERMEABILITY; CELLOPHANE; CYCLODEXTRINS; DEXAMETHASONE; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; FEMALE; HUMANS; HYDROCORTISONE; MATHEMATICAL COMPUTING; MEMBRANES, ARTIFICIAL; MICE; MICE, INBRED HRS; SKIN; SKIN ABSORPTION;

EID: 0141701162     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00182-5     Document Type: Article

References (31)

1. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci. 85(10):1996;1017-1025.
2. Rajewski R.A., Stella V.J. Pharmaceutical applications of cyclodextrins. II. In vivo drug delivery. J. Pharm. Sci. 86(2):1996;1142-1168.
3. Irie T., Uekama K. Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation. J. Pharm. Sci. 86(2):1997;147-162.
4. K.H. Fromming. J. Szejtli, Cyclodextrins in Pharmacy, vol. 5, Kluwer, Dordrecht, 1994.
5. T. Loftsson. N. Bodor, in: E.W. Smith, H.I. Mailbach (Eds.), Percutaneous Penetration Enhancers, CRC Press, Boca Raton, FL, 1995, pp. 335-342.
6. Loftsson T., Stefansson E. Effect of cyclodextrin on the topical delivery of drugs to the eye. Drug Dev. Ind. Pharm. 23(5):1997;473-481.
7. Kawahara K., Ueda H., Tomono K., Nagai T. Effect of diethyl β-cyclodextrin on the release and absorption behaviour. STP Pharma Sci. 2(6):1992;506-513.
8. 1 through hairless mouse skin: combined use of carboxymethyl-ethyl-β-cyclodextrin and penetration enhancers. J. Pharm. Pharmacol. 44:1992;119-121.
9. Loftsson T., Sigurdardottir A.M., Olafsson J.H. Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation. Int. J. Pharm. 115:1995;255-258.
10. Vollmer V., Müller B.W., Mesens J., Wilffert B., Peters T. In vivo skin pharmacokinetic of liarozole: percutaneous absorption studies with different formulations of cyclodextrins derivatives in rats. Int. J. Pharm. 99:1993;51-58.
11. Loftsson T., Sigurdardottir A.M. The effect of polyvinylpyrrolidone and hydroxypropyl methylcellulose on HPβCD complexation of hydrocortisone and its permeability through hairless mouse skin. Eur. J. Pharm. Sci. 2:1994;297-301.
12. Sigurdardottir A.M., Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm. 126:1995;73-78.
13. Kristmundsdottir T., Loftsson T., Holbrook W.P. Formulation and clinical evaluation of hydrocortisone solution for the treatment of oral disease. Int. J. Pharm. 139:1996;63-68.
14. Kublik H., Bock T.K., Schreier H., Muller B.W. Nasal absorption of 17β-estradiol from different cyclodextrin inclusion formulations in sheep. Eur. J. Pharm. Biopharm. 42(5):1996;320-324.
15. Schipper N.G., Verhoef J.C., Romeijn S.G., Merkus F.W. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif. Tissue Int. 56(4):1995;280-282.
16. van Doorne H. Interactions between cyclodextrins and ophthalmic drugs. Eur. J. Pharm. Biopharm. 39(4):1993;133-139.
17. Jarho P., Urtti A., Pate D.W., Suhonen P., Jarvinen T. Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 137:1996;209-216.
18. Jarho P., Jarvinen K., Urtti A., Stella V.J., Jarvinen T. Modified β-cyclodextrin (SBE7-β-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. Int. J. Pharm. Pharmacol. 48:1996;264-270.
19. Loftsson T., Fridriksdottir H., Thorisdottir S., Stefansson E., Sigurdardottir A.M., Gudmundsson O., Sigthorsson T. 2-Hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci. 1:1994;175-180.
20. Loftsson T., Stefansson E., Kristinsson J.K., Fridriksdottir H., Sverrisson T., Gudmundsdottir G., Thorisdottir S. Topically effective acetazolamide eye-drop solution in man. Pharm. Sci. 6:1996;277-279.
21. J. Szejtli, Cyclodextrin Technology, Kluwer, Dordrecht, 1988.
22. E.R. Cooper. D.C. Patel, in: D.W. Osborne (Ed.), Anton H. Amann, vol. 42, Marcel Dekker, New York, 1990, pp. 1-12.
23. Arima H., Adachi H., Irie T., Uekama K., Pitha J. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by β-cyclodextrin derivatives: increased absorption and localized activation of prodrug in rats. Pharm. Res. 7(11):1990;1152-1156.
24. D. Duchene, D. Wouessidjewe, in: S. Dumitriu (Ed.), Polysaccharides in Medical Applications, Marcel Dekker, New York, 1996, pp. 575-602.
25. Loftsson T., Fridriksdottir H., Sigurdardottir A.M., Ueda H. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110:1994;169-177.
26. J. Savolainen, K. Jarvinen, H. Taipale, P. Jarho, T. Loftsson, T. Jarvinen, Coadministration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm. Res. (in press).
27. T. Loftsson, Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie (in press).
28. Y.W. Chien, in: Y.W. Chien (Ed.), Transdermal Controlled Systemic Medications, vol. 31, Marcel Dekker, New York, 1987, pp. 1-22.
29. Meidan M.V., Docker M., Walmsley A.D., Irwin W.J. Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption. Pharm. Res. 15(1):1998;85-92.
30. Illel B., Schaefer H., Wepierre J., Doucet O. Follicles play an important role in percutaneous absorption. J. Pharm. Sci. 80(5):1991;424-427.
31. Larhed A.W., Artursson P., Bjork E. The Influence of Intestinal mucus components on the diffusion of drugs. Pharm. Res. 15(1):1998;66-71.